Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 494
Immune Disorders Drugs 208
Drug Discovery 169
Cardiovascular Drugs 165
Infectious Diseases Drugs 140
Biopharmaceuticals 131
Clinical Trials 128
Endocrine and Metabolic Disorders Drugs 113
Central Nervous System Drugs 107
Musculoskeletal Disorders Drugs 102
Pharmaceuticals 99
Hematological Drugs 85
Leukemia Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 64
Dermatological Drugs 59
Diabetes Drugs 57
Brain Cancer Drugs 50
Skin Cancer Drugs 50
Respiratory Drugs 45
Mental Disorders Drugs 44
Gastrointestinal Drugs 43
Lung Cancer Drugs 41
Drug Delivery 39
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 36
Pharmaceutical Manufacturing 33
Liver Cancer Drugs 30
Infusions and Injectables 30
Analgesics 27
Bladder Cancer Drugs 26
Antibiotics 26
Drugs by Therapeutic Area 25
Kidney Cancer Drugs 22
HIV/AIDS Drugs 21
Colon Cancer Drugs 20
Pancreatic Cancer Drugs 20
Prostate Cancer Drugs 18
Urological Disorders Drugs 18
Schizophrenia Drugs 17
Ovarian Cancer Drugs 16
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Breast Cancer Drugs 14
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Psoriasis Drugs 14
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Vaccines 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Transdermal and Transmucosal Drug Delivery 8
Alzheimer's Disease Drugs 8
Uterine Cancer Drugs 6
Company Reports 5
Pharmacoeconomics 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



273 reviews

2,539 Results (Page 62 of 127)
- Relevance
  Sort by

Multiple Myeloma Drugs Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3945EUR$4,490USD£3,403GBP

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
42 Pages
Global

From

€3075EUR$3,500USD£2,653GBP

Leukemia Therapeutics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3945EUR$4,490USD£3,403GBP

Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3945EUR$4,490USD£3,403GBP

Systemic Lupus Erythematosus - Pipeline Review, H2 2020

 Drug Pipelines
November 2020
816 Pages
Global

From

€2197EUR$2,500USD£1,895GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Non-Hodgkin Lymphoma Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
112 Pages
Global

From

€4174EUR$4,750USD£3,600GBP

Irritable Bowel Disease Market (2024 Edition): Analysis By Drug Class (Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes), By Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)

 Report
March 2024
250 Pages
Global

From

€2153EUR$2,450USD£1,857GBP

Follicular Lymphoma - Pipeline Insight, 2025

 Clinical Trials
April 2025
150 Pages
Global

From

€2197EUR$2,500USD£1,895GBP

Acute Myeloid Leukemia Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3945EUR$4,490USD£3,403GBP

Pruritus Therapeutics - Global Strategic Business Report

 Report
July 2025
192 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

Multiple Myeloma Drugs Market Report by Therapy, Drug Type, End-User, Distribution Channel, and Region 2024-2032

 Report
August 2024
138 Pages
Global

From

€2635EUR$2,999USD£2,273GBP

Diuretics Market Report 2025

 Report
April 2025
175 Pages
Global

From

€3945EUR$4,490USD£3,403GBP

Atrial Fibrillation - Global Clinical Trials Review, H2, 2021

 Clinical Trials
November 2021
929 Pages
Global

From

€2197EUR$2,500USD£1,895GBP

B-cell Lymphoma- Pipeline Insight, 2025

 Clinical Trials
April 2025
450 Pages
Global

From

€4393EUR$5,000USD£3,790GBP

Myelodysplastic Syndrome (MDS) Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
February 2025
185 Pages
Global

From

€3361EUR$3,825USD£2,899GBP

€3954EUR$4,500USD£3,411GBP

Nasopharyngeal Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
July 2022
521 Pages
Global

From

€2197EUR$2,500USD£1,895GBP

Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2025

 Clinical Trials
April 2025
240 Pages
Global

From

€2636EUR$3,000USD£2,274GBP

Regenerative Medicine Market by Product (Stem Cell [Autologous, Allogenic], Immunotherapy, Gene Therapy, Tissue Engineering), Application (Musculoskeletal, Cancer, Dermatology, Wound care, Cardiovascular Diseases, Eye Disorders) - Forecast to 2028

 Report
January 2024
293 Pages
Global

From

€4349EUR$4,950USD£3,752GBP

Idiopathic Pulmonary Fibrosis - Global Strategic Business Report

 Report
July 2025
181 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

The Vaccine Adjuvants Market by Type of Vaccine Adjuvant, Route of Administration, Target Therapeutic Area and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

 Report
May 2022
231 Pages
Global

From

€4217EUR$4,799USD£3,637GBP

2,539 Results (Page 62 of 127)
- 1
- 60
- 61
- 62
- 63
- 64

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.